MENU
+Compare
LFCR
Stock ticker: NASDAQ
AS OF
Sep 17, 04:38 PM (EDT)
Price
$7.76
Change
-$0.10 (-1.27%)
Capitalization
294.03M

LFCR Lifecore Biomedical Forecast, Technical & Fundamental Analysis

Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges... Show more

LFCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for LFCR with price predictions
Sep 16, 2025

Aroon Indicator for LFCR shows an upward move is likely

LFCR's Aroon Indicator triggered a bullish signal on September 09, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 185 similar instances where the Aroon Indicator showed a similar pattern. In of the 185 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 64 cases where LFCR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on September 15, 2025. You may want to consider a long position or call options on LFCR as a result. In of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for LFCR just turned positive on September 15, 2025. Looking at past instances where LFCR's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

LFCR moved above its 50-day moving average on September 15, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for LFCR crossed bullishly above the 50-day moving average on September 16, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LFCR advanced for three days, in of 275 cases, the price rose further within the following month. The odds of a continued upward trend are .

LFCR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LFCR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. LFCR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: LFCR's P/B Ratio (222.222) is very high in comparison to the industry average of (17.157). P/E Ratio (51.231) is within average values for comparable stocks, (74.281). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.889). LFCR has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.030). P/S Ratio (2.124) is also within normal values, averaging (46.266).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LFCR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
LFCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

LFCR is expected to report earnings to rise 425.00% to -31 cents per share on October 02

Lifecore Biomedical LFCR Stock Earnings Reports
Q3'25
Est.
$-0.31
Q2'25
Missed
by $0.02
Q1'25
Missed
by $0.33
Q4'24
Beat
by $0.02
Q3'24
Missed
by $0.04
The last earnings report on August 07 showed earnings per share of -5 cents, missing the estimate of -3 cents. With 11.35K shares outstanding, the current market capitalization sits at 294.03M.
A.I. Advisor
published General Information

General Information

a manufacturer of polymer products for food and agricultural products, medical devices and licensed partner applications

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Industrial Specialties
Address
3515 Lyman Boulevard
Phone
+1 952 368-4300
Employees
459
Web
https://www.lifecore.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SPXSY47.310.11
+0.24%
SPIRAX GROUP PLC
CHBJF0.91N/A
N/A
China Citic Bank Corp., Ltd.
FUGRF12.77N/A
N/A
Furgo NV
QTEYF0.23N/A
N/A
Questerre Energy Corp.
UDOCF0.14-0.01
-4.98%
UNIDOC HEALTH CORP.

LFCR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, LFCR has been loosely correlated with NBIX. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if LFCR jumps, then NBIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LFCR
1D Price
Change %
LFCR100%
+2.34%
NBIX - LFCR
36%
Loosely correlated
+0.33%
SHPH - LFCR
31%
Poorly correlated
+3.17%
ALKS - LFCR
30%
Poorly correlated
+3.28%
PBH - LFCR
29%
Poorly correlated
+0.37%
AMRX - LFCR
29%
Poorly correlated
-0.51%
More

Groups containing LFCR

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LFCR
1D Price
Change %
LFCR100%
+2.34%
Pharmaceuticals: Generic
industry (221 stocks)
10%
Poorly correlated
+0.09%